<DOC>
	<DOCNO>NCT02805153</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety PEG-rhG-CSF patient breast cancer receive chemotherapy</brief_summary>
	<brief_title>PEG-rhG-CSF Patients With Breast Cancer Receiving Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patients age 18 70 year diagnosis breast cancer patient chemotherapy naive Karnofsky Performance Status â‰¥ 70 Written inform consent acquire uncontrolled infection Have accept radiotherapy within 4 week anticipate study pregnancy Other situation investigator consider contraindication study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>PEG-rhG-CSF</keyword>
</DOC>